Article Text

other Versions

Download PDFPDF
Randomised controlled trial
PREDIMED trial: Mediterranean diet may reduce the risk of type 2 diabetes
  1. Michel de Lorgeril
  1. School of Medicine of the Grenoble University, La Tronche, France
  1. Correspondence to Michel de Lorgeril
    PRETA – TIMC – IMAG, Equipe Coeur & Nutrition, Faculté de Médecine, Domaine de la Merci, Université de Grenoble, 38706 La Tronche, France; michel.delorgeril{at}ujf-grenoble.fr

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on:

Context

The incidence of type 2 diabetes is increasing and has been associated with the Westernisation of dietary habits. The Mediterranean dietary pattern (Med diet) may be a way to reduce the incidence of type 2 diabetes. In a trial, it was shown to reduce the need for antidiabetic drugs in diabetic patients,1 and an epidemiological study suggested a lower incidence of diabetes with increasing adherence to the Med diet.2 However, its role in the prevention of diabetes has not been investigated so far in a randomised trial.

Methods

The Prevención con Dieta Mediterránea (PREDIMED) study is a three-arm randomised trial to assess the effects of two Med diets (supplemented with either olive oil or mixed nuts) versus a low-fat control …

View Full Text

Footnotes

  • Competing interests None.